PERSPECTIVE THERAPEUTICS, INC. Research and Development Expense
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Research and Development Expense of $21.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $21.54M, a 29.63% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $21.37M, a 49.12% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $32.92M, a 155.56% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $20.34M, a 69.10% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for fiscal 2025 was $84.22M, a 102.26% increase from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for fiscal 2024 was $41.64M, a 95.38% increase from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for fiscal 2023 was $21.31M, a 2318.96% increase from fiscal 2022.
- PERSPECTIVE THERAPEUTICS, INC. research and development expense for fiscal 2022 was $881.00K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.54M 10-Q · filed 2026-08-10 | $42.92M 10-Q · filed 2026-08-10 | $75.84M derived: sum of 3 quarters · filed 2026-08-10 | $96.18M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $21.37M 10-Q · filed 2026-05-11 | $54.30M derived: sum of 2 quarters · filed 2026-05-11 | $74.64M derived: sum of 3 quarters · filed 2026-05-11 | $91.25M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $32.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $53.26M derived: sum of 2 quarters · filed 2026-03-16 | $69.88M derived: sum of 3 quarters · filed 2026-08-10 | $84.22M 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $20.34M 10-Q · filed 2025-11-10 | $36.96M derived: sum of 2 quarters · filed 2026-08-10 | $51.29M 10-Q · filed 2025-11-10 | $64.17M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $16.62M 10-Q · filed 2026-08-10 | $30.95M 10-Q · filed 2026-08-10 | $43.84M derived: sum of 3 quarters · filed 2026-08-10 | $55.86M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $14.33M 10-Q · filed 2026-05-11 | $27.21M derived: sum of 2 quarters · filed 2026-05-11 | $39.24M derived: sum of 3 quarters · filed 2026-05-11 | $48.52M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $24.91M derived: sum of 2 quarters · filed 2026-03-16 | $34.19M derived: sum of 3 quarters · filed 2026-03-16 | $41.64M 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | $12.03M 10-Q · filed 2025-11-10 | $21.30M derived: sum of 2 quarters · filed 2025-11-10 | $28.75M 10-Q · filed 2025-11-10 | $35.84M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $9.28M 10-Q · filed 2025-08-13 | $16.73M 10-Q · filed 2025-08-13 | $23.81M derived: sum of 3 quarters · filed 2025-08-13 | $29.36M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $7.45M 10-Q · filed 2025-05-12 | $14.53M derived: sum of 2 quarters · filed 2025-05-12 | $20.08M derived: sum of 3 quarters · filed 2025-05-12 | $25.45M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $7.08M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-03-28 | $12.63M derived: sum of 2 quarters · filed 2025-03-28 | $18.00M derived: sum of 3 quarters · filed 2025-03-28 | $21.31M 10-K/A · filed 2025-03-28 | ||||
| 2023-09-30 | $5.55M 10-Q · filed 2024-11-12 | $5.72M 10-Q · filed 2023-11-14 | $10.92M derived: sum of 2 quarters · filed 2024-11-12 | $14.23M 10-Q · filed 2024-11-12 | $15.23M 10-Q · filed 2023-11-14 | $13.99M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $5.37M 10-Q · filed 2024-08-13 | $5.65M 10-Q · filed 2023-08-11 | $8.68M 10-Q · filed 2024-08-13 | $9.51M 10-Q · filed 2023-08-11 | $8.44M derived: sum of 3 quarters · filed 2024-08-13 | $9.15M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $3.31M 10-Q · filed 2024-05-15 | $3.86M 10-Q · filed 2023-05-15 | $3.07M derived: sum of 2 quarters · filed 2024-05-15 | $3.78M derived: sum of 3 quarters · filed 2024-05-15 | $4.57M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$240.00K derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | $468.00K 10-K · filed 2024-03-28 | $1.30M 10-KT · filed 2023-05-01 | $1.26M derived: sum of 3 quarters · filed 2024-03-28 | $881.00K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $708.00K 10-Q · filed 2023-11-14 | $1.50M derived: sum of 2 quarters · filed 2023-11-14 | $2.05M 10-Q · filed 2023-11-14 | $2.59M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $796.00K 10-Q · filed 2023-08-11 | $1.34M 10-Q · filed 2023-08-11 | $1.88M derived: sum of 3 quarters · filed 2023-08-11 | $850.00K 10-K · filed 2024-03-28 | $2.58M 10-K · filed 2022-09-28 | |||
| 2022-03-31 | $549.00K 10-Q · filed 2023-05-15 | $1.08M derived: sum of 2 quarters · filed 2023-05-15 | $1.79M 10-Q · filed 2022-05-13 | $2.25M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $535.00K 10-Q · filed 2022-02-09 | $1.24M 10-KT · filed 2023-05-01 | $1.71M derived: sum of 3 quarters · filed 2023-05-01 | $2.07M derived: sum of 4 quarters · filed 2023-05-01 | ||||
| 2021-09-30 | $702.00K 10-Q · filed 2022-11-14 | $1.17M derived: sum of 2 quarters · filed 2023-05-01 | $1.53M derived: sum of 3 quarters · filed 2023-05-01 | $1.82M derived: sum of 4 quarters · filed 2023-05-01 | ||||
| 2021-06-30 | $468.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | $830.00K derived: sum of 2 quarters · filed 2023-05-01 | $1.11M derived: sum of 3 quarters · filed 2023-05-01 | $1.43M 10-KT · filed 2023-05-01 | ||||
| 2021-03-31 | $362.00K 10-Q · filed 2022-05-13 | $647.00K derived: sum of 2 quarters · filed 2022-05-13 | $959.00K 10-Q · filed 2022-05-13 | $1.28M derived: sum of 4 quarters · filed 2023-05-01 | ||||
| 2020-12-31 | $285.00K 10-Q · filed 2022-02-09 | $597.00K 10-Q · filed 2022-02-09 | $919.00K derived: sum of 3 quarters · filed 2023-05-01 | $1.21M derived: sum of 4 quarters · filed 2023-05-01 | ||||
| 2020-09-30 | $312.00K 10-Q · filed 2021-11-10 | $634.00K derived: sum of 2 quarters · filed 2023-05-01 | $928.00K derived: sum of 3 quarters · filed 2023-05-01 | $1.21M derived: sum of 4 quarters · filed 2023-05-01 | ||||
| 2020-06-30 | $322.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | $616.00K derived: sum of 2 quarters · filed 2023-05-01 | $893.00K derived: sum of 3 quarters · filed 2023-05-01 | $1.13M 10-KT · filed 2023-05-01 | ||||
| 2020-03-31 | $294.00K 10-Q · filed 2021-05-14 | $571.00K derived: sum of 2 quarters · filed 2021-05-14 | $804.00K 10-Q · filed 2021-05-14 | $1.15M derived: sum of 4 quarters · filed 2021-09-27 | ||||
| 2019-12-31 | $277.00K 10-Q · filed 2021-02-09 | $510.00K 10-Q · filed 2021-02-09 | $851.00K derived: sum of 3 quarters · filed 2021-09-27 | $1.15M derived: sum of 4 quarters · filed 2021-09-27 | ||||
| 2019-09-30 | $233.00K 10-Q · filed 2020-11-13 | $574.00K derived: sum of 2 quarters · filed 2021-09-27 | $873.00K derived: sum of 3 quarters · filed 2021-09-27 | $1.29M derived: sum of 4 quarters · filed 2021-09-27 | ||||
| 2019-06-30 | $341.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | $640.00K derived: sum of 2 quarters · filed 2021-09-27 | $1.05M derived: sum of 3 quarters · filed 2021-09-27 | $1.47M 10-K · filed 2021-09-27 | ||||
| 2019-03-31 | $299.00K 10-Q · filed 2020-05-13 | $713.00K derived: sum of 2 quarters · filed 2020-05-13 | $1.13M 10-Q · filed 2020-05-13 | $1.71M derived: sum of 4 quarters · filed 2020-09-25 | ||||
| 2018-12-31 | $414.00K 10-Q · filed 2020-02-12 | $834.00K 10-Q · filed 2020-02-12 | $1.41M derived: sum of 3 quarters · filed 2020-09-25 | $1.88M derived: sum of 4 quarters · filed 2020-09-25 | ||||
| 2018-09-30 | $420.00K 10-Q · filed 2019-11-13 | $992.00K derived: sum of 2 quarters · filed 2020-09-25 | $1.47M derived: sum of 3 quarters · filed 2020-09-25 | $1.80M derived: sum of 4 quarters · filed 2020-09-25 | ||||
| 2018-06-30 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $1.04M derived: sum of 2 quarters · filed 2020-09-25 | $1.39M derived: sum of 3 quarters · filed 2020-09-25 | $1.75M 10-K · filed 2020-09-25 | ||||
| 2018-03-31 | $473.00K 10-Q · filed 2019-05-10 | $813.00K derived: sum of 2 quarters · filed 2019-05-10 | $1.17M 10-Q · filed 2019-05-10 | $1.49M derived: sum of 4 quarters · filed 2019-09-27 | ||||
| 2017-12-31 | $340.00K 10-Q · filed 2019-02-13 | $701.00K 10-Q · filed 2019-02-13 | $1.02M derived: sum of 3 quarters · filed 2019-09-27 | $1.34M derived: sum of 4 quarters · filed 2019-09-27 | ||||
| 2017-09-30 | $362.00K 10-Q · filed 2018-11-09 | $678.00K derived: sum of 2 quarters · filed 2019-09-27 | $1.00M derived: sum of 3 quarters · filed 2019-09-27 | $1.16M derived: sum of 4 quarters · filed 2019-09-27 | ||||
| 2017-06-30 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $643.00K derived: sum of 2 quarters · filed 2019-09-27 | $793.00K derived: sum of 3 quarters · filed 2019-09-27 | $965.00K 10-K · filed 2019-09-27 | ||||
| 2017-03-31 | $327.00K 10-Q · filed 2018-05-04 | $477.00K derived: sum of 2 quarters · filed 2018-05-04 | $649.00K 10-Q · filed 2018-05-04 | $792.00K derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2016-12-31 | $150.00K 10-Q · filed 2018-02-09 | $322.00K 10-Q · filed 2018-02-09 | $465.00K derived: sum of 3 quarters · filed 2018-09-26 | $648.00K derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2016-09-30 | $172.00K 10-Q · filed 2017-11-14 | $315.00K derived: sum of 2 quarters · filed 2018-09-26 | $498.00K derived: sum of 3 quarters · filed 2018-09-26 | $556.00K derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2016-06-30 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26 | $326.00K derived: sum of 2 quarters · filed 2018-09-26 | $384.00K derived: sum of 3 quarters · filed 2018-09-26 | $528.00K 10-K · filed 2018-09-26 | $528.05K 10-K · filed 2016-09-09 | |||
| 2016-03-31 | $183.00K 10-Q · filed 2017-05-10 | $183.19K 10-Q · filed 2016-05-10 | $241.00K derived: sum of 2 quarters · filed 2017-05-10 | $385.00K 10-Q · filed 2017-05-10 | $385.32K 10-Q · filed 2016-05-10 | $541.36K derived: sum of 4 quarters · filed 2017-09-28 | ||
| 2015-12-31 | $58.00K 10-Q · filed 2017-02-09 | $58.23K 10-Q · filed 2016-02-09 | $202.00K 10-Q · filed 2017-02-09 | $202.14K 10-Q · filed 2016-02-09 | $358.36K derived: sum of 3 quarters · filed 2017-09-28 | $499.76K derived: sum of 4 quarters · filed 2017-09-28 | ||
| 2015-09-30 | $144.00K 10-Q · filed 2016-11-09 | $143.90K 10-Q · filed 2015-11-09 | $300.36K derived: sum of 2 quarters · filed 2017-09-28 | $441.76K derived: sum of 3 quarters · filed 2017-09-28 | $582.39K derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-06-30 | $156.36K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $297.76K derived: sum of 2 quarters · filed 2017-09-28 | $438.39K derived: sum of 3 quarters · filed 2017-09-28 | $615.00K 10-K · filed 2017-09-28 | $614.77K 10-K · filed 2015-09-14 | |||
| 2015-03-31 | $141.40K 10-Q · filed 2016-05-10 | $282.03K derived: sum of 2 quarters · filed 2016-05-10 | $458.64K 10-Q · filed 2016-05-10 | $656.81K derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-12-31 | $140.63K 10-Q · filed 2016-02-09 | $317.24K 10-Q · filed 2016-02-09 | $515.41K derived: sum of 3 quarters · filed 2016-09-09 | $669.02K derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-09-30 | $176.61K 10-Q · filed 2015-11-09 | $374.78K derived: sum of 2 quarters · filed 2016-09-09 | $528.39K derived: sum of 3 quarters · filed 2016-09-09 | $698.42K derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-06-30 | $198.17K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | $351.78K derived: sum of 2 quarters · filed 2016-09-09 | $521.81K derived: sum of 3 quarters · filed 2016-09-09 | $668.80K 10-K · filed 2016-09-09 | ||||
| 2014-03-31 | $153.61K 10-Q · filed 2015-05-15 | $323.64K derived: sum of 2 quarters · filed 2015-05-15 | $470.63K 10-Q · filed 2015-05-15 | $651.95K derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-12-31 | $170.03K 10-Q · filed 2015-02-17 | $317.02K 10-Q · filed 2015-02-17 | $498.34K derived: sum of 3 quarters · filed 2015-09-14 | $653.48K derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-09-30 | $146.99K 10-Q · filed 2014-11-14 | $328.31K derived: sum of 2 quarters · filed 2015-09-14 | $483.45K derived: sum of 3 quarters · filed 2015-09-14 | $632.63K derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-06-30 | $181.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $336.46K derived: sum of 2 quarters · filed 2015-09-14 | $485.63K derived: sum of 3 quarters · filed 2015-09-14 | $627.11K 10-K · filed 2015-09-14 | ||||
| 2013-03-31 | $155.14K 10-Q · filed 2014-05-15 | $304.31K derived: sum of 2 quarters · filed 2014-05-15 | $445.79K 10-Q · filed 2014-05-15 | $653.15K derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | $149.18K 10-Q · filed 2014-02-14 | $290.65K 10-Q · filed 2014-02-14 | $498.01K derived: sum of 3 quarters · filed 2014-02-14 | $630.25K derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-09-30 | $141.47K 10-Q · filed 2013-11-14 | $348.84K derived: sum of 2 quarters · filed 2013-11-14 | $481.08K derived: sum of 3 quarters · filed 2013-11-14 | $670.74K derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $207.37K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | $339.60K derived: sum of 2 quarters · filed 2013-09-30 | $529.26K derived: sum of 3 quarters · filed 2013-09-30 | $780.58K 10-K · filed 2013-09-30 | ||||
| 2012-03-31 | $132.24K 10-Q · filed 2013-05-15 | $321.90K derived: sum of 2 quarters · filed 2013-05-15 | $573.21K 10-Q · filed 2013-05-15 | $1.18M derived: sum of 4 quarters · filed 2013-05-15 | ||||
| 2011-12-31 | $189.66K 10-Q · filed 2013-02-14 | $440.98K 10-Q · filed 2013-02-14 | $1.05M derived: sum of 3 quarters · filed 2013-02-14 | $1.29M derived: sum of 4 quarters · filed 2013-02-14 | ||||
| 2011-09-30 | $251.31K 10-Q · filed 2012-11-14 | $858.18K derived: sum of 2 quarters · filed 2012-11-14 | $1.10M derived: sum of 3 quarters · filed 2012-11-14 | $1.12M derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | $606.87K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $851.05K derived: sum of 2 quarters · filed 2012-10-26 | $866.66K derived: sum of 3 quarters · filed 2012-10-26 | $981.19K 10-K/A · filed 2012-10-26 | ||||
| 2011-03-31 | $244.18K 10-Q · filed 2012-05-15 | $259.80K derived: sum of 2 quarters · filed 2012-05-15 | $374.32K 10-Q · filed 2012-05-15 | |||||
| 2010-12-31 | $15.61K 10-Q · filed 2012-02-14 | $130.13K 10-Q · filed 2012-02-14 | ||||||
| 2010-09-30 | $114.52K 10-Q/A · filed 2011-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |